Several studies on the mechanisms of radioresistance in NSCLC have suggested the potential involvement of either p53 mutations, altered expression of survival proteins including X-linked inhibitor of apoptosis protein (XIAP) and survivin, or activation of phosphoinositide 3-kinase (PI3K)/AKT signaling [29]. The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.